Discover open access scientific publications

Search, annotate, share and cite publications

Publications by HFCM Van Mierlo

Comparison of the AT1-receptor Blocker, Candesartan Cilexetil, and the ACE Inhibitor, Lisinopril, in Fixed Combination With Low Dose Hydrochlorothiazide in Hypertensive Patients

Journal of Human Hypertension
Internal Medicine
2000English

Related publications

Candesartan Cilexetil/Hydrochlorothiazide Combination Treatment Versus High-Dose Candesartan Cilexetil Monotherapy in Patients With Mild to Moderate Cardiovascular Risk (CHILI Triple T)

Vascular Health and Risk Management
2011English

Long-Term Efficacy of Combination Therapy With Losartan and Low-Dose Hydrochlorothiazide in Patients With Uncontrolled Hypertension

International Heart Journal
MedicineCardiovascular MedicineCardiology
2007English

Effect on Hemodynamics of ACE Inhibitor, Lisinopril, And, .BETA.1-selective .BETA.-blocker, Betaxolol in Essential Hypertension.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1990English

A Prospective and Open Label Study of Use of Cilnidipine and Chlorthalidone Fixed Dose Combination in Indian Hypertensive Patients, Intolerant or Uncontrolled on Amlodipine and Hydrochlorothiazide Combination

International Journal of Advances in Medicine
2017English

Orthostatic Hypotension and Therapy With an Ace Inhibitor in Hypertensive Patients

Serbian Journal of Experimental and Clinical Research
Medicine
2017English

Candesartan Cilexetil Improves Left Ventricular Function, Left Ventricular Hypertrophy, and Endothelial Function in Patients With Hypertensive Heart Disease

Circulation Journal
MedicineCardiovascular MedicineCardiology
2002English

Effectiveness of Open-Label Losartan/Hydrochlorothiazide Combination Therapy in Asian Patients With Hypertension Not Controlled With ACE Inhibitor or ARB Monotherapy

Hypertension Research
Internal MedicineCardiovascular MedicinePhysiologyCardiology
2009English

Effects of an AT1 Receptor Antagonist, an ACE Inhibitor and a Calcium Channel Antagonist on Cardiac Gene Expressions in Hypertensive Rats

British Journal of Pharmacology
Pharmacology
1996English

Converting Enzyme Inhibitor or AT1-Receptor Blocker for Decreasing Long-Term Mortality in Patients With Stroke History and Renal Dysfunction?

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2002English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy